Wiqiu Tablets
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
MFDS item code 201404405 · Approved 2014.09.26
This product's status changed to Expired on 2024.09.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (e.g., ulcers and gastritis) and Zollinger-Ellison syndrome; prevention of Mendelson syndrome
This medicinal product is used for gastrointestinal disorders such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective for conditions associated with excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It is administered before anesthesia to prevent Mendelson's syndrome and is also used in the treatment of ulcers after surgery. This medicine is used to treat gastric or duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It helps protect the gastric mucosa and regulate gastric acid secretion to improve the symptoms of these conditions.
Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. For patients with recurrent ulcers, administer 2 tablets once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets four times daily. Zollinger-Ellison syndrome: Start treatment at an initial dose of 2 tablets three times daily and increase as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions: When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. Preanesthetic medication (prevention of Mendelson's syndrome): Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.
This medicine is not recommended for patients undergoing dialysis treatment or those with kidney dysfunction. Additionally, it should not be administered to patients who have had allergic reactions to this medicine or its ingredients, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or women who may become pregnant, and to premature infants and neonates. Patients on potassium-restricted diets should also exercise caution before using this medicine. Patients with liver dysfunction, a history of drug allergies, elderly patients, and those who have previously had kidney dysfunction should also use this medicine with caution. Patients taking non-steroidal anti-inflammatory drugs concurrently should be monitored closely, and since it can mask gastric cancer symptoms, patients with gastric ulcers or those over middle age presenting new symptoms of dyspepsia should ensure malignancy has been ruled out before using this treatment. Patients with gastric or duodenal ulcers associated with Helicobacter pylori infection require eradication therapy, and special caution is warranted for critically ill patients or those with hypophosphatemia and swallowing difficulties when using this medication. While using this medicine, rare allergic reactions, skin rash, blood abnormalities, liver dysfunction, gastrointestinal symptoms, neurological disturbances, myalgia, and other various side effects may occur, and any unusual symptoms should be reported to healthcare professionals immediately. Do not use for prolonged periods, and if there is no therapeutic effect, switching to another medication is advisable. Elderly patients and those with chronic lung diseases or diabetes may be at increased risk for pneumonia, so caution is advised, and activities requiring alertness, such as driving or operating dangerous machinery, should be avoided if dizziness or drowsiness occurs. This medication can interact with other drugs, so inform healthcare professionals of any other medications being taken. It is advisable for pregnant or breastfeeding women to avoid using this medication. Safety for children has not been established, so it should not be administered to them. In case of overdose, emergency measures such as vomiting or gastric lavage may be required, and if necessary, blood dialysis may be performed for removal. This medicine reduces gastric acid secretion, which may promote bacterial growth in the stomach, so regular eye examinations are recommended with long-term use.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a sealed container to prevent exposure to air or moisture, ideally at a temperature between 1 degree and 30 degrees Celsius. Proper storage maintains the medicine's effectiveness and prevents degradation.
This medicine is a round white film-coated tablet.
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.